2-Aminopurine
Showing 26 - 50 of >10,000
Non-muscle Invasive Bladder Cancer Trial (TARA-002)
Not yet recruiting
- Non-muscle Invasive Bladder Cancer
- TARA-002
- (no location specified)
Jul 14, 2023
COVID-19 Trial in United States (mRNA-CR-04 vaccine 10µg, mRNA-CR-04 vaccine 30µg, mRNA-CR-04 vaccine 100µg)
Not yet recruiting
- COVID-19
- mRNA-CR-04 vaccine 10μg
- +3 more
-
San Diego, California
- +3 more
Aug 1, 2023
Visual Acuity Trial in United States (Acuvue Oasys 1 Day for Astigmatism, TRA100/TRA200 series toric contact lens with
Not yet recruiting
- Visual Acuity
- Acuvue Oasys 1 Day for Astigmatism
- TRA100/TRA200 series toric contact lens with HEVL-blocking chromophore
-
Jacksonville, Florida
- +9 more
Mar 10, 2023
Sars-CoV-2 Infection Trial in South Africa (Alveavax-v1.2, Janssen Ad26.COV2.S)
Completed
- Sars-CoV-2 Infection
- Alveavax-v1.2
- Janssen Ad26.COV2.S
-
Bloemfontein, Free State, South Africa
- +7 more
May 2, 2023
COVID-19 Trial in United States (NVX-CoV2373 (5µg), NVX-CoV2601 (5µg), NVX-CoV2601(5µg))
Not yet recruiting
- COVID-19
- NVX-CoV2373 (5μg)
- +6 more
-
Birmingham, Alabama
- +47 more
Jul 2, 2023
Facio-Scapulo-Humeral Dystrophy Trial (ARO-DUX4 for Injection, Placebo)
Not yet recruiting
- Facio-Scapulo-Humeral Dystrophy
- ARO-DUX4 for Injection
- Placebo
- (no location specified)
Nov 13, 2023
Advanced Breast Cancer Trial in Changsha (TQB3909 tablets)
Recruiting
- Advanced Breast Cancer
- TQB3909 tablets
-
Changsha, Hunan, ChinaHunan Cancer Hospital
Mar 16, 2023
Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent, Leukemia Trial in Boston (Cytokine-Induced Memory-like Natural Killer
Not yet recruiting
- Acute Myeloid Leukemia
- +3 more
- Cytokine-Induced Memory-like Natural Killer Cells
- +2 more
-
Boston, Massachusetts
- +1 more
Nov 22, 2023
COVID-19 Transmission and Morbidity in Malawi
Recruiting
- SARS CoV 2 Infection
- SARS CoV 2 Vaccination
-
Boston, Massachusetts
- +1 more
Aug 6, 2023
Advanced Solid Tumor Trial in Guangzhou (YL201 for Injection)
Recruiting
- Advanced Solid Tumor
- YL201 for Injection
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Sep 21, 2023
Prostate Cancer Metastatic Trial in New York, Knoxville (HB-302/HB-301 Alternating 2-Vector Therapy)
Recruiting
- Prostate Cancer Metastatic
- HB-302/HB-301 Alternating 2-Vector Therapy
-
New York, New York
- +1 more
Feb 1, 2023
Type 2 Diabetes Trial in Seoul (SGLT2 inhibitor)
Not yet recruiting
- Type 2 Diabetes Mellitus
- SGLT2 inhibitor
-
Seoul, Seodaemun-gu, Korea, Republic ofSeverance Hospital
Nov 17, 2023
Diabetes, Type 2 Trial in Seoul (administration of UI068, administration of UIC202205, UIC202206)
Completed
- Diabetes Mellitus, Type 2
- administration of UI068
- administration of UIC202205, UIC202206
-
Seoul, Gwanak-gu, Korea, Republic ofH plus Yangji Hospital
Nov 15, 2023
SARS-CoV-2, Influenza Trial in Canada, United States (mRNA-1083, Placebo, Influenza Vaccine)
Not yet recruiting
- SARS-CoV-2
- Influenza
- mRNA-1083
- +3 more
-
Anniston, Alabama
- +172 more
Oct 18, 2023
Alzheimer Trial in Houston (Interleukin-2, Placebo)
Recruiting
- Alzheimer Disease
- Interleukin-2
- Placebo
-
Houston, TexasHouston Methodist Research Institute
Oct 17, 2023
Multiple Myeloma Trial in Wollongong (IBI3003)
Not yet recruiting
- Multiple Myeloma
-
Wollongong, New South Wales, AustraliaWollongong Private Hospital
Oct 18, 2023
Gorlin Syndrome Trial (Patidegib Topical Gel, Vehicle Gel)
Not yet recruiting
- Gorlin Syndrome
- Patidegib Topical Gel
- Vehicle Gel
- (no location specified)
Sep 15, 2023
Atopic Dermatitis, Atopic Dermatitis Eczema, Atopic Dermatitis of Scalp Trial (HY209GEL Active, Placebo)
Not yet recruiting
- Atopic Dermatitis
- +2 more
- HY209GEL Active
- Placebo
- (no location specified)
Aug 31, 2023
Achondroplasia Trial (Navepegritide, Placebo for Navepegritide)
Not yet recruiting
- Achondroplasia
- Navepegritide
- Placebo for Navepegritide
- (no location specified)
Oct 6, 2023
Lung Cancer, NSCLC, Brain Metastases Trial (Alectinib, Stereotactic Radiosurgery)
Not yet recruiting
- Lung Cancer
- +2 more
- Alectinib
- Stereotactic Radiosurgery
- (no location specified)
Aug 4, 2023
Lung Cancer, Interstitial Lung Disease Trial in London, Montreal (N-Acetyl cysteine, Dexamethasone Oral, N-Acetyl cysteine
Not yet recruiting
- Lung Cancer
- Interstitial Lung Disease
- N-Acetyl cysteine
- +3 more
-
London, Ontario, Canada
- +1 more
Aug 1, 2023
Breast Cancer Stage II, Breast Cancer Stage III, Solid Tumor Trial in Wuxi ([18F]SF-DEVD-2, [18F]-FDG)
Recruiting
- Breast Cancer Stage II
- +2 more
-
Wuxi, Jiangsu, ChinaAffiliated Hospital of Jiangnan University
Apr 22, 2023